LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | CP466722 | 0.12 | uM | LJP5 | 3 | I11 | 72 | hr | 929 | 3386 | 3228 | 1.0489 | 1.0687 |
Hs 578T | Crizotinib | 0.12 | uM | LJP5 | 1 | A23 | 72 | hr | 929 | 3285 | 3228 | 1.0176 | 1.0248 |
Hs 578T | Crizotinib | 0.12 | uM | LJP5 | 2 | A23 | 72 | hr | 929 | 3167 | 3228 | 0.9811 | 0.9734 |
Hs 578T | Crizotinib | 0.12 | uM | LJP5 | 3 | A23 | 72 | hr | 929 | 3190 | 3228 | 0.9882 | 0.9834 |
Hs 578T | Momelotinib | 0.12 | uM | LJP5 | 1 | P11 | 72 | hr | 929 | 2754 | 3228 | 0.8531 | 0.7938 |
Hs 578T | Momelotinib | 0.12 | uM | LJP5 | 2 | P11 | 72 | hr | 929 | 2792 | 3228 | 0.8649 | 0.8103 |
Hs 578T | Momelotinib | 0.12 | uM | LJP5 | 3 | P11 | 72 | hr | 929 | 2711 | 3228 | 0.8398 | 0.7751 |
Hs 578T | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 929 | 1723 | 3228 | 0.5338 | 0.3453 |
Hs 578T | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 929 | 1749 | 3228 | 0.5418 | 0.3566 |
Hs 578T | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 929 | 1797 | 3228 | 0.5567 | 0.3775 |
Hs 578T | Dasatinib | 0.12 | uM | LJP6 | 1 | I05 | 72 | hr | 929 | 1209 | 3228 | 0.3745 | 0.1217 |
Hs 578T | Dasatinib | 0.12 | uM | LJP6 | 2 | I05 | 72 | hr | 929 | 1123 | 3228 | 0.3479 | 0.0843 |
Hs 578T | Dasatinib | 0.12 | uM | LJP6 | 3 | I05 | 72 | hr | 929 | 1283 | 3228 | 0.3975 | 0.1539 |
Hs 578T | Dovitinib | 0.12 | uM | LJP5 | 1 | E23 | 72 | hr | 929 | 1887 | 3228 | 0.5846 | 0.4166 |
Hs 578T | Dovitinib | 0.12 | uM | LJP5 | 2 | E23 | 72 | hr | 929 | 2093 | 3228 | 0.6484 | 0.5062 |
Hs 578T | Dovitinib | 0.12 | uM | LJP5 | 3 | E23 | 72 | hr | 929 | 2100 | 3228 | 0.6505 | 0.5093 |
Hs 578T | Enzastaurin | 0.12 | uM | LJP5 | 1 | D17 | 72 | hr | 929 | 3257 | 3228 | 1.0090 | 1.0126 |
Hs 578T | Enzastaurin | 0.12 | uM | LJP5 | 2 | D17 | 72 | hr | 929 | 3278 | 3228 | 1.0155 | 1.0217 |
Hs 578T | Enzastaurin | 0.12 | uM | LJP5 | 3 | D17 | 72 | hr | 929 | 3256 | 3228 | 1.0087 | 1.0122 |
Hs 578T | Erlotinib | 0.12 | uM | LJP5 | 1 | M23 | 72 | hr | 929 | 3061 | 3228 | 0.9483 | 0.9273 |
Hs 578T | Erlotinib | 0.12 | uM | LJP5 | 2 | M23 | 72 | hr | 929 | 3064 | 3228 | 0.9492 | 0.9286 |
Hs 578T | Erlotinib | 0.12 | uM | LJP5 | 3 | M23 | 72 | hr | 929 | 3090 | 3228 | 0.9572 | 0.9399 |
Hs 578T | Foretinib | 0.12 | uM | LJP5 | 1 | H11 | 72 | hr | 929 | 2799 | 3228 | 0.8671 | 0.8134 |
Hs 578T | Foretinib | 0.12 | uM | LJP5 | 2 | H11 | 72 | hr | 929 | 2851 | 3228 | 0.8832 | 0.8360 |
Hs 578T | Foretinib | 0.12 | uM | LJP5 | 3 | H11 | 72 | hr | 929 | 2846 | 3228 | 0.8816 | 0.8338 |